Skip to content

HB 646 · Kentucky · 2026RS · Billy

Skip to content

Home
/
Bills
/
Kentucky
/
2026RS
/
HB 646

Kentucky · 2026RS session · house

HB 646AN ACT relating to the use of pharmaceuticals to intentionally terminate life.

Status: In committee
Latest action: 2026-02-23 — to Judiciary (H)
Primary sponsor: N. Tate

Civil Actions
Crimes and Punishments
Drugs and Medicines
Health and Medical Services
Licensing
State Agencies
Corrections Impact

Track this bill

Sponsors

N. Tate · primaryprimary
T. Roberts · primaryprimary

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy Kentucky bill RSS

SB

S. Baker · primaryprimary

KBK. Banta · primaryprimary

JDJ. Decker · primaryprimary

SDS. Doan · primaryprimary

RDR. Dotson · primaryprimary

DFD. Fister · primaryprimary

DGD. Gordon · primaryprimary

DHD. Hale · primaryprimary

JHJ. Hodgson · primaryprimary

THT. Huff · primaryprimary

Versions

IntroducedFeb 13, 2026

Legislative history

Feb 23, 2026
to Judiciary (H)
Feb 13, 2026
to Committee on Committees (H)
Feb 13, 2026
introduced in House

Official sources

Version 0PDF

About this page

Is this the official Kentucky bill page?: No — this is Billy’s public legislative record for HB 646. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track HB 646, get alerts, annotate diffs, and export Word work product.